Genocea Biosciences
GNCAQ----
Genocea Biosciences (GNCAQ)
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Genocea Biosciences Analyst Rating
View MoreForecast & Rating
Jul 8, 2022Price forecast
$6.005999900.00%
Forecast & RatingBuy
1analysts
- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- MorningStar · Mar 31 at 01:55 AM
Genflow Biosciences PLC Announces Total Voting Rights
- Tip Ranks · Mar 13 at 10:37 AM
Gufic Biosciences Settles SEBI Compliance Penalties Over Independent Director Appointment
- Tip Ranks · Mar 9 at 06:33 AM
Genedrive shareholders back fundraising as company expands pharmacogenetic footprint
- StockTitan · Mar 1 at 10:55 PM
Genflow Biosciences PLC Announces Result of GM | GENFF Stock News
